Monthly vs. quarterly shot: which controls ovarian function better in young breast cancer patients?
NCT ID NCT07610733
First seen May 31, 2026 · Last updated Jun 15, 2026 · Updated 3 times
Summary
This study looks at young women (ages 18-45) with hormone-sensitive breast cancer who are already on a 3-month hormone injection to suppress ovarian function. Researchers want to see if switching to a monthly injection keeps estrogen levels lower and more stable. About 100 participants will be randomly assigned to either stay on the 3-month shot or switch to the monthly one, with estrogen levels checked at 3 and 6 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.
Conditions inferred from the trial description
These were inferred from the trial's summary, not listed by the trial registrant.